ENTERPRISE: THE TRANSFORMATIONAL ACTION OF THE BUSINESS MODEL IN BRAZILIAN DIAGNOSTIC MEDICINE

Abstract

The present case demonstrates the Pardini Group's business model transformation process, a national reference in diagnostic medicine. With the operation in full expansion, the number of exams carried out grew at an average rate of 15% per year, driven mainly by the performance in the Lab-to-Lab (L2L) modality. The management team, primarily physicians, infectious disease specialists, and biochemists, focused on the search for new knowledge to implement a new business and management model. Thus, the Enterprise project was born, a worldwide unprecedented laboratory automation project. The project aims to increase production capacity, speed of processing exams, and reduce costs, maintaining high levels of accuracy and reliability. In addition, we describe the reformulation of the logistics system and significant investments in integrations and digital transformations, ranging from the creation of software and hardware, thus promoting the emergence of the MyPardini digital platform. The case brings together practical evidence of the Pardini Group's innovative culture, its leaders' role, and the ability to deliver with agility in the L2L market. These are some findings that promote the materialization of the Enterprise, a fact that boosted the last negotiations of the acquisition process by Fleury.